Vera Therapeutics, Inc. (VERA) Stock Analysis — Probabli.AI
AI-powered analysis for VERA (Vera Therapeutics, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
Last price: $34.95 · Market cap: $2.6B · AI consensus: Bullish
Vera Therapeutics presents a compelling bullish investment opportunity due to its strong pipeline, recent positive developments, and substantial analyst backing with high price targets. Despite some challenges such as ongoing patent disputes and negative EPS surprise history, strategic moves like FDA fast track designation and international expansion significantly bolster its growth potential.…
Probabilistic 1-Year Outlook
- Bull 5500% · Neutral 3000% · Bear 1500%
- Vera Therapeutics has several bullish signals: a strong analyst consensus with a median target implying significant upside (+123.5%), recent positive headlines including FDA fast track designation and key partnerships,…
5-Year Outlook
- Bull 6500% · Neutral 2500% · Bear 1000%
SWOT Highlights
- Strength: Strong analyst consensus with significant upside targets
- Strength: Recent FDA fast track designation for lead candidate
- Risk: Negative average EPS surprise
- Risk: Ongoing patent dispute
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
14 Wall Street analysts rate VERA a STRONG BUY with a mean price target of $78.
Analysis generated Aug 27, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/VERA.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.